MedTech

MedTech welcomes the addition of Anne Schneiderman, partner and patent attorney with Harris Beach, to MedTech's Board of...

MedTech Association welcomes Mike Riedlinger, the Program Manager for Technology Commercialization and Manager of the Rochester Bioventure Center, to its Board of...

AdvaMed and the State Medical Technology Alliance, including MedTech, released a comprehensive policy agenda focused on state-based initiatives that will foster an environment of growth and patient access to the latest in medical innovation.

MedTech's Board of Directors appointed Jessica M. Crawford as president of the association, to succeed it's former president, Heather R. Erickson. who left the organization in July 2012. Crawford has more than 10 years of public advocacy experience.

Professionals throughout the Upstate New York area were elected to MedTech's 2012-2013 Board of Directors. MedTech is the hub of the bioscience and medical technology industries in New York.

New York state Lt. Governor Bob Duffy, along with president and CEO of AngioDynamics, Joe Devivo, addressed an audience of 95 bioscience and medical technology professionals at MedTech's Annual Members Dinner in Verona, NY on June 7.

Excell Partners, a state-supported seed fund, presented its first Excell Challenge award this month. The award is an avenue to support the commercial success of promising companies coming out of New York State's Pre-Seed Workshop program.

Senator Kirsten Gillibrand toured Welch Allyn last Friday and addressed members of MedTech--the hub of Upstate New York's Bio/Med industry--who voiced concerns about R&D tax credits, investors and higher education.

MedTech members are working with clinical researchers from medical universities, including The University at Buffalo, to address unmet or under-met healthcare needs. The most recent discussion, hosted by Greatbatch Medical, centered on cardiology.

U.S. Rep. Richard Hanna (NY-24) visited two biotech start-up companies in his district late last month--NovaSterilis and Rheonix. Legislative understanding and support for biotech companies is important, given the challenges these companies face.